MSCO Quality and Innovation Grant is a grant from the Massachusetts Society of Clinical Oncology (MSCO) that funds quality improvement and innovation projects aimed at improving cancer care for patients in Massachusetts. The program supports oncology professionals, including trainees and early-career physicians, and includes travel grants of up to $1,500 for attending national conferences such as ASCO or NCCN.

The program is open to individuals or groups seeking to improve cancer care for patients in Massachusetts. Award amounts vary by grant type; travel grant deadline is January 31 for NCCN and March 31 for ASCO meetings. Applicants should be Massachusetts-based oncology practitioners or trainees.

Massachusetts Society of Clinical Oncologists - Early Career "The Voice of Oncology in Massachusetts" Oncology in Massachusetts Distinguished Researcher Award Pharmaceutical & Copay Assistance In addition to all the other membership benefits, MSCO is investing in the future of oncology by supporting the professional development and research of young clinicians, fellows and internal medicine residents.

The Massachusetts Society of Clinical Oncology (MSCO) is pleased to announce that, as part of our efforts to support the growth and future of the oncology profession, we will be providing grants for oncology professionals from Massachusetts to travel to national annual conferences. Trainees and early-career physicians can apply for travel grants to help with the cost of attending the NCCN or ASCO meeting.

The travel grant is a reimbursement award (up to $1,500) to assist with associated expenses. Among the recipients of the MSCO Travel Grant will be one to two trainee(s) of an Massachusetts ACGME-accredited training program and one young clinician (with less than three years of practice). Grant Deadline is January 31st.

Grant D eadline is March 31st. Thank you to everyone who applied. Our 2024 ASCO travel grants were awarded to the following individuals: Madhan Srinivasan, MD, Internal Medical Resident, St.

Vincent Vera Kazakova, MD, Fellow, UMass Maria de Fatima Reyes, MD, Gynecology Oncology Fellow, BIDMC Prarthna Bhardwaj, MD, Oncologist, Baystate We are thrilled that MSCO was able to support you on your journey. The Massachusetts Society of Clinical Oncologists (MSCO) is proud to annually fund one Young Investigator Award (YIA) for a qualified Massachusetts applicant through Conquer Cancer, the ASCO Foundation.

We encourage all eligible Massachusetts Fellows and Trainees to apply. The YIA is a one-year, $57,500 grant that provides research funding to promising physicians to support their transition from final years of subspecialty training to faculty appointment and to encourage and promote quality research in clinical oncology. For questions about eligibility, please contact Conquer Cancer at grants@conquer.

org .

David Gritsch, MD, PhD, Massachusetts General Hospital Novel Biomarkers of Immunotherapy Response in Patients with Brain Metastases" Leon Pappas, MD, PhD , Massachusetts General Hospital “Clinical and molecular basis for the immunosuppressive nature of liver metastases in patients with metastatic Colorectal Cancer” Arielle Medford, MD , Massachusetts General Hospital “MDM2 inhibition for patients with hormone-receptor positive, GATA3-mutant metastatic breast cancer” Evan Chen, MD, a Physician, Division of Leukemia, Dana-Farber Cancer Institute.

A Phase 1 study of adding navitoclax to the combination of venetoclax and decitabine for advanced myeloid malignancies. Praful Ravi, MBBChir, MRCP , a Medical Oncologist at the Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute, is the recipient of the inaugural YIA Award supported by MSCO. A Phase 2 trial of palbociclib in combination with axitinib and avelumab in metastatic clear cell renal cell carcinoma.

Annual Poster Competition Welcome to the MSCO Annual Poster Competition, an esteemed platform for students, residents and fellows to showcase their groundbreaking research and clinical insights during our annual meeting. This event invites submissions for the prestigious Walter Kagan Research Poster Award and the Michael Goldstein Clinical Vignette Poster Award.

MSCO Cancer Survivorship Research Grant Who Can Apply: Fellows at an accredited college or early career physician. Must be located in Massachusetts.

Purpose: The Massachusetts Society of Clinical Oncology (MSCO) is pleased to announce that, as part of our efforts to support the growth and future of the oncology profession, we will be providing a grant for an early career oncology professional from Massachusetts to conduct a research project focusing on cancer survivorship.

Application Deadline: August 31, 2024 MSCO Quality and Innovation Grant The purpose of the MSCO Quality & Innovation Grant is to improve the care of patients in the state of Massachusetts living with a diagnosis of cancer. Funding will be provided for an individual or a group seeking to improve the deliver of cancer care, the quality of cancer care, treatment of cancer, or comfort of patients suffering from cancer.

Adapting the Electronic Patient Reported Outcomes (EPRO) Intervention to Improve Cancer Care Delivery and Clinical Outcomes of Limited-English Proficiency (LEP) Individuals Diagnosed with Advanced Gastrointestinal or Breast Cancer Jessica Zerillo, MD, PhD and Meghan Shea, MD Oral Chemotherapy Management with Electronic Patient Reporting--A Community and Academic Hybrid Model Chris Wong Quiles, MD, MPH, CPPS A Bundle to Standardize Home Medication Administration and Reduce Errors in Pediatric Oncology Patients Marjory Charlot, MD, MPH, MSc Feasibility, acceptability and effectiveness of the MBSR for smoking cessation in cancer patients 860 Winter Street, Waltham, MA, 02451 Powered by Wild Apricot Membership Software